Follow
Magdalena G Krzystolik
Magdalena G Krzystolik
Assistant Professor, Retina Service, Mass Eye and Ear, Boston, MA
Verified email at meei.harvard.edu
Title
Cited by
Cited by
Year
Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment
MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ...
Archives of ophthalmology 120 (3), 338-346, 2002
8042002
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
SD Solomon, K Lindsley, SS Vedula, MG Krzystolik, BS Hawkins
Cochrane Database of Systematic Reviews, 2014
6382014
Antiangiogenic therapy with anti‐vascular endothelial growth factor modalities for neovascular age‐related macular degeneration
SS Vedula, M Krzystolik
Cochrane Database of Systematic Reviews, 2008
1482008
The ocular manifestations and transmission of COVID-19: recommendations for prevention
DM Dockery, SG Rowe, MA Murphy, MG Krzystolik
The Journal of emergency medicine 59 (1), 137-140, 2020
1472020
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
E Li, S Donati, KB Lindsley, MG Krzystolik, G Virgili
Cochrane Database of Systematic Reviews, 2020
1082020
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture
CS Ament, DN Zacks, AM Lane, M Krzystolik, DJ D’Amico, S Mukai, ...
Archives of ophthalmology 124 (7), 957-966, 2006
912006
Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a cochrane systematic review
SD Solomon, KB Lindsley, MG Krzystolik, SS Vedula, BS Hawkins
Ophthalmology 123 (1), 70-77. e1, 2016
802016
Complications of intraocular tamponade: silicone oil versus intraocular gas
MG Krzystolik, DJ D'Amico
International ophthalmology clinics 40 (1), 187-200, 2000
562000
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy
MG Krzystolik, T Filippopoulos, JF Ducharme, JI Loewenstein
Archives of Ophthalmology 124 (6), 920-921, 2006
312006
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
U Reddy, M Krzystolik
Cochrane Database of Systematic Reviews, 2006
192006
Diagnostic and therapeutic challenges of sarcoidosis
M Krzystolik, WJ Power, CS Foster
International ophthalmology clinics 38 (1), 61-76, 1998
191998
EXOGENOUSASPERGILLUS NIGERENDOPHTHALMITIS IN A PATIENT WITH A FILTERING BLEB
MG KRZYSTOLIK, TA Ciulla, TM Topping, AS Baker
Retina 17 (5), 461-462, 1997
161997
Wyburn-Mason syndrome associated with cutaneous reactive angiomatosis and central retinal vein occlusion
AB Callahan, D Skondra, M Krzystolik, Y Yonekawa, D Eliott
Ophthalmic Surgery, Lasers and Imaging Retina 46 (7), 760-762, 2015
152015
Cost and selection of ophthalmic anti-vascular endothelial growth factor agents
E Li, PB Greenberg, I Voruganti, MG Krzystolik
RI Med J 99 (5), 15-17, 2016
122016
The use of mobile applications as low-vision aids: a pilot study
DMD COA, MG Krzystolik
Rhode Island Medical Journal 103 (8), 69-72, 2020
102020
Anterior-segment ultrasound biomicroscopy in a patient with AIDS and bilateral angle-closure glaucoma secondary to uveal effusions
MG Krzystolik, M Kuperwasser, RM Low, EB Dreyer
Archives of Ophthalmology 114 (7), 878-879, 1996
81996
Antiangiogenic agents as an adjunctive treatment for complicated neovascular glaucoma
T Filippopoulos, JF Ducharme, JI Loewenstein, MG Krzystolik
Investigative Ophthalmology & Visual Science 47 (13), 4476-4476, 2006
72006
Nurse-administered intravitreal injections: a systematic review
E Li, PB Greenberg, MG Krzystolik
Graefe's Archive for Clinical and Experimental Ophthalmology 253, 1619-1621, 2015
52015
A 5-year retrospective assessment of clinical presentation associated with sports injury in young people presenting to a tertiary eye center
DM Dockery, MA Harrington, MF Gardiner, MG Krzystolik
Journal of Pediatric Ophthalmology & Strabismus 58 (6), 377-384, 2021
42021
Treatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
E Li, S Donati, G Virgili, MG Krzystolik
Cochrane Database of Systematic Reviews 2016 (5), CD012208, 2016
32016
The system can't perform the operation now. Try again later.
Articles 1–20